CA ATRA (Tretinoin) is a prescription medication used in the treatment of acute promyelocytic leukemia (APL), a type of cancer that affects the blood and bone marrow. It contains the active ingredient All-Trans Retinoic Acid (Tretinoin).
CA ATRA is used in combination with other chemotherapy medications to treat acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia. It works by promoting the maturation of immature white blood cells, which helps to reduce the number of cancer cells in the blood and bone marrow.
HOW TO USE:
CA ATRA capsules should be taken orally, with or without food, as directed by the doctor. Patients should never exceed the recommended dosage. The dosage and duration of treatment will be determined by the doctor based on the patient’s medical history and response to treatment.
CA ATRA capsules should be stored at room temperature, between 20°C to 25°C (68°F to 77°F). Keep it away from direct sunlight, heat, and moisture. Ensure that the medication is kept out of reach of children and pets.
Mechanism of action:
CA ATRA contains All-Trans Retinoic Acid (Tretinoin), which is a derivative of vitamin A that promotes the differentiation of immature white blood cells into mature cells. It works by binding to specific receptors in the cells, which triggers a series of biochemical reactions that lead to the maturation of the cells and the suppression of cancer cell growth.
– CA ATRA should only be used under medical supervision and by individuals who have been diagnosed with acute promyelocytic leukemia (APL).
– Patients with liver or kidney problems, high cholesterol levels, diabetes, or other medical conditions should inform their doctor before using CA ATRA, as these conditions may affect the safety or effectiveness of the medication.
– CA ATRA may interact with other medications and affect their effectiveness or increase the risk of side effects. Patients should inform their doctor if they are taking any prescription or over-the-counter medications, vitamins, or herbal supplements.
CA ATRA is contraindicated for patients who:
– Have an allergy to Tretinoin or any of its ingredients
– Are pregnant or breastfeeding
– Have severe liver or kidney problems
CA ATRA may interact with other medications and affect their effectiveness or increase the risk of side effects. Patients should inform their doctor if they are taking any prescription or over-the-counter medications, vitamins, or herbal supplements.
In the event of an overdose, patients should seek immediate medical attention. Symptoms of an overdose may include headache, nausea, vomiting, and skin rash.
CA ATRA may cause side effects, which may vary in severity and depend on the dosage and duration of treatment. Common side effects include:
– Loss of appetite
Less common but serious side effects may include:
– Allergic reactions
– Blood clots
– Liver problems
Patients should inform their doctor immediately if they experience any serious or persistent side effects.